Bookmark and Share

Compound Summary for: CID 133021


Also known as: 156897-06-2; ML-3000; UNII-P5T6BYS22Y; Licofelone [INN]; ML 3000; CHEMBL300982; Licofelone, ML-3000; BRN 6823674
Molecular Formula: C23H22ClNO2   Molecular Weight: 379.87928   InChIKey: UAWXGRJVZSAUSZ-UHFFFAOYSA-N
Developed by the German pharmaceutical company, Merckle GmbH, together with EuroAlliance partners Alfa Wassermann and Lacer, licofelone (ML3000) is a dual COX/LOX inhibitor and the first member of this new class of analgesic and anti-inflammatory drugs. It is currently under evaluation as a treatment for osteoarthritis (OA), the most common form of arthritis. Although phase III trials have been successfully completed in OA patients no dates for regulatory submission have yet been given.   From: DrugBank
Show subcontent titlesTable of Contents
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Biomolecular Interactions and Pathways
Biological Test Results
Chemical and Physical Properties
_ _